1. Home
  2. MCD vs MRK Comparison

MCD vs MRK Comparison

Compare MCD & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McDonald's Corporation

MCD

McDonald's Corporation

HOLD

Current Price

$304.22

Market Cap

217.9B

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$102.33

Market Cap

260.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCD
MRK
Founded
1940
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
217.9B
260.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MCD
MRK
Price
$304.22
$102.33
Analyst Decision
Buy
Buy
Analyst Count
25
14
Target Price
$326.35
$108.21
AVG Volume (30 Days)
3.3M
15.2M
Earning Date
11-05-2025
10-30-2025
Dividend Yield
2.45%
3.34%
EPS Growth
2.90
58.08
EPS
11.72
7.56
Revenue
$26,264,000,000.00
$64,235,000,000.00
Revenue This Year
$4.17
$1.82
Revenue Next Year
$5.66
$5.10
P/E Ratio
$25.90
$13.48
Revenue Growth
1.25
1.68
52 Week Low
$276.53
$73.31
52 Week High
$326.32
$105.84

Technical Indicators

Market Signals
Indicator
MCD
MRK
Relative Strength Index (RSI) 48.45 70.14
Support Level $304.03 $93.90
Resistance Level $313.30 $105.84
Average True Range (ATR) 4.43 3.22
MACD 0.41 1.08
Stochastic Oscillator 28.62 80.65

Price Performance

Historical Comparison
MCD
MRK

About MCD McDonald's Corporation

McDonald's is the largest restaurant owner-operator in the world, with 2024 system sales of $131 billion across more than 43,000 stores and 115 markets. McDonald's pioneered the franchise model, building its footprint through partnerships with independent restaurant franchisees and master franchise partners around the globe. The firm earns roughly 60% of its revenue from franchise royalty fees and lease payments, with most of the remainder coming from company-operated stores across its three core segments: the United States, internationally operated markets, and international developmental/licensed markets.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: